337 related articles for article (PubMed ID: 25974331)
1. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
[TBL] [Abstract][Full Text] [Related]
4. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.
Chung GE; Kim D; Kim W; Yim JY; Park MJ; Kim YJ; Yoon JH; Lee HS
J Hepatol; 2012 Jul; 57(1):150-6. PubMed ID: 22425701
[TBL] [Abstract][Full Text] [Related]
7. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
[TBL] [Abstract][Full Text] [Related]
9. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.
Lee YB; Ha Y; Chon YE; Kim MN; Lee JH; Park H; Kim KI; Kim SH; Rim KS; Hwang SG
Clin Mol Hepatol; 2019 Mar; 25(1):52-64. PubMed ID: 30360031
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B.
Liu L; Li P; Mi Y; Liu Y; Liu Y; Zhang P
Medicine (Baltimore); 2019 Nov; 98(46):e17945. PubMed ID: 31725651
[TBL] [Abstract][Full Text] [Related]
11. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease.
Liang J; Han T; Gao YT; Jing L; Ma Z
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838
[TBL] [Abstract][Full Text] [Related]
12. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
[TBL] [Abstract][Full Text] [Related]
14. Importance of thyroid-stimulating hormone levels in liver disease.
Kim HJ
J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1133-1137. PubMed ID: 32809954
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors.
Peng D; Han Y; Ding H; Wei L
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1082-8. PubMed ID: 18707599
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-21 Is Associated with Early Antiviral Response in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease.
Liu X; Shen Z; Zhang H; Liang J; Lin H
J Interferon Cytokine Res; 2016 Jun; 36(6):367-73. PubMed ID: 26840345
[TBL] [Abstract][Full Text] [Related]
17. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
[TBL] [Abstract][Full Text] [Related]
18. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?
Kumar M; Rastogi A; Singh T; Behari C; Gupta E; Garg H; Kumar R; Bhatia V; Sarin SK
J Gastroenterol Hepatol; 2013 Jul; 28(7):1194-201. PubMed ID: 23425053
[TBL] [Abstract][Full Text] [Related]
19. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
[TBL] [Abstract][Full Text] [Related]
20. Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects.
Tao Y; Gu H; Wu J; Sui J
Endocr Res; 2015; 40(2):74-8. PubMed ID: 25330278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
